Meanwhile, the expression levels of FKBP1A mRNA were higher in bladder cancer, gastric cancer, head and neck cancer, kidney cancer, lymphoma, myeloma, ovarian cancer, prostate cancer and sarcoma compared to the normal tissues. This evidence concerns the gene FKBP1A and urinary bladder carcinoma.